These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35179795)

  • 1. Prognostic value of prognostic nutritional index and its variations in advanced non-small-cell lung cancer patients treated with anlotinib monotherapy.
    Chen T; Liang G; Xiang Z; He J; Xu X; Tang M
    J Clin Lab Anal; 2022 Apr; 36(4):e24300. PubMed ID: 35179795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
    Tang M; Song C; Zhang Y; Xu X; Wang C; Zhang Z; Chen T
    Lipids Health Dis; 2021 Nov; 20(1):165. PubMed ID: 34801029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib.
    Chen T; Song C; Liang G; Xu X; Wang C; Zhang Z; Tang M
    Dis Markers; 2022; 2022():5879137. PubMed ID: 35356064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of patients with advanced lung cancer treated with anlotinib: a retrospective cohort study.
    Fan B; Tan X; Lou Y; Zheng Y; Zhang L; Wu X
    J Int Med Res; 2021 Oct; 49(10):3000605211046173. PubMed ID: 34758674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib.
    Liu J; Li S; Zhang S; Yang C; Zhang L; Zhang B; Cheng Y; Wang C
    J Thorac Dis; 2020 Oct; 12(10):5765-5773. PubMed ID: 33209408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor.
    Fang Q; Yu J; Luo J; Deng Q; Chen B; He Y; Zhang J; Zhou C
    Clin Med Insights Oncol; 2022; 16():11795549221137134. PubMed ID: 36408336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of
    Li X; Cheng Y; Zhu B; Geng M; Yan P; Hu M
    Technol Cancer Res Treat; 2022; 21():15330338221080993. PubMed ID: 35443836
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
    Chen T; Tang M; Xu X; Liang G; Xiang Z; Lu Y; Wang C; Shen W
    J Clin Lab Anal; 2022 Dec; 36(12):e24772. PubMed ID: 36441595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Nutritional Index before durvalumab after chemoradiation predict the overall survival in patients with stage III non-small cell lung cancer.
    Matsuura S; Serizawa S; Yamashita R; Morikawa K; Ito Y; Hiramatsu T; Mochizuki E; Tanaka K; Akiyama N; Tsukui M; Koshimizu N; Kosugi T
    Ann Med; 2023 Dec; 55(1):2196089. PubMed ID: 37043179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
    Nishihara-Kato F; Imai H; Tsuda T; Wasamoto S; Nagai Y; Kishikawa T; Miura Y; Ono A; Yamada Y; Masubuchi K; Osaki T; Nakagawa J; Umeda Y; Minemura H; Kozu Y; Taniguchi H; Ohta H; Kaira K; Kagamu H
    Oncology; 2024; 102(1):30-42. PubMed ID: 37598676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage treatment with anlotinib for advanced non-small cell lung cancer.
    Wu D; Nie J; Dai L; Hu W; Zhang J; Chen X; Ma X; Tian G; Han J; Han S; Long J; Wang Y; Zhang Z; Fang J
    Thorac Cancer; 2019 Jul; 10(7):1590-1596. PubMed ID: 31183998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer.
    Li L; Liu W; Wang Y; Zhang Q; Chi C; Bai Q; Xu C; Yang R
    J Chemother; 2021 Nov; 33(7):492-498. PubMed ID: 33818318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict the Overall Survival of Advanced Non-Small Cell Lung Cancer Patients.
    Matsuura S; Morikawa K; Ito Y; Kubota T; Ichijo K; Mochizuki E; Akiyama N; Uehara M; Harada M; Tsukui M; Koshimizu N
    Nutr Cancer; 2022; 74(5):1606-1613. PubMed ID: 34431441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prognostic nutritional index change on prognosis after colorectal cancer surgery under propofol or sevoflurane anesthesia.
    Zhang L; Liu C; Yan Q; Cai X
    BMC Anesthesiol; 2024 Jan; 24(1):12. PubMed ID: 38172695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib.
    Chen D; Xu J; Zhao Y; Chu T; Zhong H; Han B; Zhong R
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):401-406. PubMed ID: 31691871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial.
    Cheng Y; Han B; Li K; Wang Q; Zhang L; Shi J; Wang Z; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Zhu J
    Cancer Med; 2020 Apr; 9(8):2621-2630. PubMed ID: 32064794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer].
    Xu WJ; Kang YM; Zhou L; Chen FF; Song YH; Zhang CQ
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):146-149. PubMed ID: 28219213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.